Company
Every investor coverage indicates participated in a round The Minderoo Foundation raised.
Companies The Minderoo Foundation acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
Stories naming The Minderoo Foundation. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Melbourne pharmaceutical company ENA Respiratory has received US$5 million from California's Flu Lab to advance clinical testing of its nasal immune-boosting antiviral candidate INNA-051.
Melbourne's ENA Respiratory has won a further US$3.18 million US Defense Department contract to widen its INNA-051 Phase Ib trial to younger adults, extending the US$8.18 million the agency had already committed.
Also Brandon BioCatalyst portfolio·Brandon Capital portfolio·Brandon Capital portfolio·enarespiratory.com
Law firm Lander & Rogers advised AirTree Ventures on FairSupply's AUD6.3 million Series A, with Tidal Ventures, Minderoo Foundation and QIC participating; the firm also recalls recent raises by QuintessenceLabs and Logmaster.